Chimerism and tolerance: From freemartin cattle and neonatal mice to humans

Human Immunology

Volumn 52, Issue 2, 1997, Pages 155-161

  Jankowski, Renee A ^a   Ildstad, Suzanne T ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CATTLE; CHIMERA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW TRANSPLANTATION; CATTLE; CHIMERA; FEMALE; FREEMARTINISM; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; MICE; PREGNANCY; TRANSPLANTATION CONDITIONING;

EID: 0030956404     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00290-X     Document Type: Article

References (52)

1. Owen RD: Immunogenic consequences of vascular anastomoses between bovine twins. Science 102:400, 1945.
2. Dunsford I, Bowley CC, Hutchison AM, Thompson JS, Sanger R, Race RR: A human blood-group chimera. Br Med J ii:81, 1953.
3. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172:603, 1953.
4. Osgood EE, Riddle MC, Mathews TJ: Aplastic anemia treated with daily transfusions and intravenous marrow; case report. Ann Intern Med 13:357, 1939.
5. Lorenz E, Uphoff D, Reid TR, Shelton E: Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 12:197, 1951.
6. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Nieman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975.
7. Thomas ED, Lochte HL, Lu WC, Ferrebee JW: Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491, 1957.
8. Thomas ED, Herman EC Jr, Greenough WB, Hager EB, Cannon JH, Sahler OD, Ferrebee JW: Irradiation and marrow infusion in leukemia. Arch Intern Med 107:95, 1961.
9. Martin PJ, Hansen JA, Storb R, Thomas ED: Human marrow transplantation: An immunological perspective. Adv Immunol 40:379, 1987.
10. Giralt SA, Champlin RE: Leukemia relapse after allogeneic marrow transplantation: A review. Blood 84:3603, 1994.
11. Hansen JA, Anasetti C, Martin PJ: The Seattle experience. In Terasaki PI, Checka JM (eds): Clinical Transplants. Los Angeles, UCLA Tissue Typing Laboratory, 1994.
12. Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST: A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 155:4179, 1995.
13. Burnet FM, Fenner F: The production of antibodies. London, MacMillan and Co, Ltd., 1949.
14. Roberts JL, Sharrow SO, Singer A: Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J Exp Med 171:935, 1990.
15. Ramsdell F, Lanta T, Fowlkes BJ: A nondeletional mechanism of thymus self-tolerance. Science 246:1038, 1989.
16. Marrack PR, Brinster L, Palmiter RB, Flauvel RH, Kapples J: The effect of thymus environment on T-cell development and tolerance. Cell 53:627, 1988.
17. Jenkins MK: The role of cell division in the induction of clonal anergy. Immunol Today 13:69, 1992.
18. Kaufman CL, Ildstad ST: Induction of donor-specific tolerance by transplantation of bone marrow. Ther Immunol 1:101, 1994.
19. Ildstad ST, Sachs DH: Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168, 1984.
20. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH: Characterization of mixed allogeneic chimeras. J Exp Med 162:231, 1985.
21. Zinkernagel RM, Althage A, Callahan G, Welsh RM: On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol 124:2356, 1980.
22. Rüedi E, Sykes M, Ildstad ST, Sachs DH: Antiviral T cell competence and restricting specificity of mixed allogeneic (P1 + P2 → P1) irradiation chimeras. Cell Immunol 121: 185, 1984.
23. Rayfield LS, Brent L: Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras. Transplantation 36:183, 1983.
24. Congdon CC: Cooperative group on bone marrow transplantation in man. Transplant Proc 11:342, 1970.
25. Leong LY, Qin S, Cobbold SP, Waldmann H: Classical transplantation tolerance in the adult: The interaction between myeloablation and immunosuppression. Eur J Immunol 22:2825, 1992.
26. van Bekkum DW: Conditioning regimens for marrow grafting. Semin Hematol 21:81, 1984.
27. Down JD, Tarbell NJ, Thames HD, Mauch PM: Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 77:661, 1991.
28. Slavin S, Strober S, Fuks Z, Kaplan HS: Induction of a specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 146:34, 1977.
29. van Bekkum DW: Radiation chimeras. Transplant Proc 11:479, 1970.
30. Ildstad ST, Wren SM, Boggs SS, Hronakes ML, Vecchini F, Van den Brink MRM: Cross-species bone marrow transplantation: Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat → mouse). J Exp Med 174:467, 1991.
31. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB: Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann Intern Med 101: 667, 1984.
32. Sharabi Y, Sachs DH: Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169:493, 1989.
33. Sharabi Y, Aksentijevich I, Sundt TM, Sachs DH, Sykes M: Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 172:195, 1990.
34. Nomoto K, Yung-Yun K, Omoto K, Umesue M, Murakami Y, Matsuzaki G, Nomoto K: Tolerance induction in a fully allogeneic combination using anti-T cell receptors-αβ monoclonal antibody, low dose irradiation, and donor bone marrow transfusion. Transplantation 59:395, 1995.
35. Gershwin ME, Goetzl EJ, Steinberg AD: Cyclophosphamide: Use in practice. Ann Intern Med 80:531, 1974.
36. Colson YL, Li H, Boggs SS, Patiene UD, Johnson PC, Ildstad ST: Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 157:2820, 1996.
37. Monaco AP, Wood ML, Russell PS: Studies on heterologous anti-lymphocyte serum in mice III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Ann NY Acad Sci 129:190, 1966.
38. Monaco AP, Wood ML: Studies on heterologous antilymphocyte serum in mice VII. Optimal cellular antigen for induction of immunologic tolerance with anti lymphocyte serum. Transplant Proc 11:489, 1970.
39. Thomas J, Carver M, Cunningham P, Park K, Gonder J, Thomas F: Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow. Transplantation 43:332, 1987.
40. Wood P, Horsburgh T, Brent L: Specific unresponsiveness to skin allografts in mice. Transplantation 31:8, 1981.
41. Qin S, Cobbold SP, Benjamin R, Waldmann H: Induction of classical transplantation tolerance in the adult. J Exp Med 169:779, 1989.
42. Cobbold SP, Martin G, Qin S, Waldmann H: Monoclonal antibodies to promote engraftment and tissue graft tolerance. Nature 323:164, 1986.
43. Korngold R, Sprent J: Lethal GVHD after bone marrow transplantation across minor histocompatibility barriers in mice: Prevention by removing mature T-cells from marrow. J Exp Med 148:1687, 1980.
44. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg J, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, Kennedy MS, Sullivan KM, Flournoy N, Storb R, Thomas ED: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664, 1985.
45. Hale G, Cobbold S, Waldmann H: T cell depletion with campath-1 in allogeneic bone marrow transplantation. Transplantation 45:753, 1988.
46. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988.
47. Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S, Freidman J, Weissman IL: Mouse hematopoietic stem cells. J Am Soc Hematol 78:1395, 1991.
48. El Badri NS, Goode RA: Lymphohemopoietic reconstitution using wheat germ agglutinin-positive hemopoietic stem cell transplantation within but not across the major histocompatibility antigen barriers. Immunology 90: 6681, 1993.
49. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST: Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84:2436, 1994.
50. Gaines BA, Colson YL, Kaufman CL, Ildstad ST: Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients Exp Hemat 24:902, 1996.
51. Sykes M, Sheard M, Sachs DH: Effects of T cell depletion in radiation bone marrow chimeras I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J Immunol 141:2282, 1988.
52. Lapidot T, Faktorowich Y, Lubin I, Reisner Y: Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+CD4- and not CD8-CD4+ thymocytes. Blood 80: 2406, 1992.